2m 2m 2m 2m 2m 2m 2m
ENLIVEN THERP (ELVN)
NASDAQ
$46.71+$0.50 (+1.08%)
Price as of Oct 02, 2026 4:29 PM EDT- $3.4BMarket Cap
- 131.98%1-Year Change
- BiotechnologyIndustry
ENLIVEN THERP (ELVN)
$46.71+$0.50 (+1.08%)
ELVN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $46.21 | ||
Change | +$0.37 (+0.81%) | ||
Open | $46.29 | ||
High | $47.23 | ||
Low | $45.70 | ||
Previous Close | $45.84 | ||
Volume | 944,890 | ||
30-Day Average Volume | 1,437,083 | ||
1-Week Change | 2.30% | ||
1-Month Change | -20.13% | ||
1-Year Change | 131.98% | ||
3-Year Change | 238.29% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 73.3M | ||
Total Assets | $910.2M | ||
Market Cap | $3.4B | ||
Enterprise Value | $3.3B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$32.5M | ||
Free Cash Flow | -$18.6M | ||
EBIT | -$32.5M | ||
EBITDA | -$32.5M | ||
Net Working Capital | $893.2M | ||
EPS | -$0.49 | ||
Enterprise Value/EBITDA | -100 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -94 | ||
PEG | 3 | ||
Price/Free Cash Flow | -182 | ||
Price/Operating Cash Flow | -183 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue